Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin irritation / corrosion

Currently viewing:

Administrative data

Endpoint:
skin irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
11. Sep. 2017 - 15. Sep. 2017
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2017
Report date:
2017

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
Version / remarks:
OECD Guideline for the Testing of Chemicals, Version 439, adopted 28. July 2015,
“In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method”
Deviations:
yes
Remarks:
The pre-incubation time was 1 hour, instead of 18- 24 hours. This can be seen as uncritical, because the pre-incubation time must be at least 1 hour (in consultation with the tissue supplier; MatTek In Vitro Life Science Laboratories).
Qualifier:
according to guideline
Guideline:
EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
Version / remarks:
Commission Regulation (EU) No. 640/2012 amending Regulation (EC) No.440/2008,
Annex III, EU method B.46 “IN VITRO SKIN IRRITATION: RECONSTRUCTED HUMAN
EPIDERMIS MODEL TEST”, adopted 06. Jul. 2012
Deviations:
yes
Remarks:
The pre-incubation time was 1 hour, instead of 18- 24 hours. This can be seen as uncritical, because the pre-incubation time must be at least 1 hour (in consultation with the tissue supplier; MatTek In Vitro Life Science Laboratories).
GLP compliance:
yes (incl. QA statement)

Test material

Constituent 1
Reference substance name:
Myo-Inositol, hexakis(dihydrogen phosphate), sodium salt
EC Number:
238-242-6
EC Name:
Myo-Inositol, hexakis(dihydrogen phosphate), sodium salt
Cas Number:
14306-25-3
Molecular formula:
C6H18O24P6.xNa
IUPAC Name:
Esters of sodium hydrogen phosphate with myo-Inositol, plant-derived (old name: myo-Inositol, hexakis(dihydrogen phosphate), sodium salt)
Test material form:
solid: bulk
Details on test material:
- Appearance: white solid powder
- Homogeneity: homogenous
- Density: 2.0401 ± 0.0009 g/cm3 at 20 ± 0.2 °C
- Moisture content: 0.1 - 10% (water is an inherent constituent of the UVCB substance)
Specific details on test material used for the study:
SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material:
Evonik Dr. Straetmans GmbH
- Expiration date of the lot/batch:
NA2253
- Purity test date:
June 2019

STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material:
The test item was stored in the test facility away from light and humidity in a closed vessel at room temperature (20 ± 5°C).
- Stability under test conditions:
H2O: unknown; EtOH: 96h; acetone: 96h; CH3CN: 96h;
DMSO: 96h
- Solubility and stability of the test substance in the solvent/vehicle:
H2O: >1 g/L; EtOH: unknown; acetone: unknown; CH3CN:
unknown; DMSO: unknown
- Reactivity of the test substance with the solvent/vehicle of the cell culture medium:
unknown

TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing:
none
- Preliminary purification step (if any):
none
- Final dilution of a dissolved solid, stock liquid or gel:
none
- Final preparation of a solid:
none

FORM AS APPLIED IN THE TEST
white solid powder (not different from that of starting material)

TYPE OF BIOCIDE/PESTICIDE FORMULATION (if applicable)
not applicable

OTHER SPECIFICS:

In vitro test system

Test system:
human skin model
Source species:
human
Cell type:
non-transformed keratinocytes
Cell source:
foreskin from a single donor
Source strain:
other: Keratinocyte strain 00267
Details on animal used as source of test system:
no animals used as source of test system
Justification for test system used:
The test system (EpiDerm Skin Irritation Test (EPI-200-SIT) is one of the validated reference methods (VRMs) included in Annex 2 the Test Guideline OECD 439. For this VRMs, pre-validation, optimisation and validation studies have been completed and the VRMs have been used to develop the present Guideline OECD 439 and the Performance Standards.
Vehicle:
other: Dulbecco’s Phosphate Buffered Saline solution
Details on test system:
RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used:
MatTek Corporation’s Reconstructed Human Epidermal Model EpiDermTM (EPI-200-SIT)
- Tissue batch number(s):
25841
- Production date:
not available
- Shipping date:
not available
- Delivery date:
13. Sep. 2017
- Date of initiation of testing:
13. Sep. 2017

TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during pre-treatment incubation:
37°C ± 1°C
- Temperature used during treatment / exposure:
37°C ± 1°C
- Temperature of post-treatment incubation (if applicable):
37°C ± 1°C

REMOVAL OF TEST MATERIAL AND CONTROLS
-Volume and number of washing steps:
1 hour after the first application, the inserts were removed from the plates using sterile forceps and rinsed immediately with DPBS in 1-minute-intervals.
After rinsing, each tissue was blotted with sterile cellulose tissue and then transferred into a new 6-well-plate with fresh assay medium (0.9 mL).
Then, the tissues were set in the incubator for 22 hours at 37 ± 1°C and 5.0 ± 0.5% CO2. After post-incubation the tissues were removed from the incubator and shaken for
5 minutes (120 rpm). Then, the inserts were transferred into fresh assay medium (0.9 mL) and were incubated for 16 hours for post-incubation at 37 ± 1°C and 5.0 ± 0.5 % CO2.
- Observable damage in the tissue due to washing:
not reported
- Modifications to validated SOP:
No deviations from the study plan were observed.

MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration:
1 mg/mL
- Incubation time:
3 hours at 37 ± 1°C and 5.0 ± 0.5% CO2.
- Spectrophotometer:
Microtiter plate photometer "Anthos Reader 2010 Flexi" (Anthos Microsysteme GmbH)
- Wavelength:
570 nm
- Filter:
570 nm
- Filter bandwidth:
not reported
- Linear OD range of spectrophotometer:
not reported

FUNCTIONAL MODEL CONDITIONS WITH REFERENCE TO HISTORICAL DATA
- Viability:
Result: 1.27 ± 0.071 (OD 540-570 nm)
Method: MTT QC assay (4 hrs, n=3)
Acceptance criteria tissue viability: 1.0-3.0 (OD 540-570 nm) (Pass)
- Barrier function:
Result (ET-50): 6.28 hours
Method: ET-50 assay (100µl 1% Triton x-100, 4 time-points, n=3, MMT assay)
Acceptance criteria for ET-50: 4.77-8.72 hours (Pass)
- Morphology:
Tissue viability and the barrier function test are within the acceptable ranges and indicate appropriate formation of the epidermal barrier, the presence of a functional stratum corneum, a viable basal cell layer, and intermediate spinous and granular layers.
- Contamination:
No contamination (sterile) (Pass)
- Reproducibility:
Values for negative control and for positive control were within the range of historical data of the test facility:
Negative control (OD): 1.965 (historical range: 0.476 - 2.471)
Positive control (% OD compared to Negative Control): 2.5% (historical range: 1.8 - 17.1%)

NUMBER OF REPLICATE TISSUES:
Three tissue replicates were used for the test item and for the controls.

CONTROL TISSUES USED IN CASE OF MTT DIRECT INTERFERENCE
The two pre-tests (testing the ability of direct MTT reduction and the testing the ability of color formation without MTT addition) both resulted in a colourless solution. Therefore, the test item is not presumed to directly reduce the MTT and further not to develop a colour without MTT addition.
As a consequence, additional tests ("Direct Reduction of MTT with freeze killed Tissues" and "Binding capacity) had not to be performed and no data correction was necessary.
- Fresh tissues / killed tissues:
not applicable
- Procedure used to prepare the killed tissues (if applicable):
not applicable
- N. of replicates:
not applicable
- Method of calculation used:
not applicable

NUMBER OF INDEPENDENT TEST SEQUENCES / EXPERIMENTS TO DERIVE FINAL PREDICTION:
One valid experiment was performed.

PREDICTION MODEL / DECISION CRITERIA (choose relevant statement)
- The test substance is considered to be corrosive or irritant to skin if the tissue viability is less or equal 50%
- The test substance is considered to be non-irritant to skin if the viability is greater than 50%.
- Justification for the selection of the cut-off point(s) if different than recommended in TG 431 and 439:
not applicable
Control samples:
yes, concurrent negative control
yes, concurrent positive control
Amount/concentration applied:
TEST MATERIAL
- Amount(s) applied (volume or weight with unit):
26.1 mg (Tissue 1)
26.3 mg (Tissue 2)
25.3 mg (Tissue 3)
- Concentration (if solution):
The tissues were wetted with 25 μL DPBS buffer before applying the test item and spreading
it to match the tissue size (mean conc. 1.012 g/mL).

VEHICLE
- Amount(s) applied (volume or weight with unit):
The tissues were wetted with 25 μL DPBS buffer before applying the test item and spreading
it to match the tissue size
- Concentration (if solution):
not applicable
- Lot/batch no. (if required):
not applicable
- Purity:
not applicable

NEGATIVE CONTROL
- Amount(s) applied (volume or weight):
30 μL DPBS buffer
- Concentration (if solution):
not applicable

POSITIVE CONTROL
- Amount(s) applied (volume or weight):
30 μL 5% SDS solution
- Concentration (if solution):
SDS solution (5%)
Duration of treatment / exposure:
1 hour (25 minutes at RT and 35 minutes at 37 ± 1°C)
Duration of post-treatment incubation (if applicable):
- 22 hours at 37 ± 1°C and 5.0 ± 0.5% CO2 in 0.9 mL fresh assay medium
- shaken for 5 minutes (120 rpm)
- 16 hours at 37 ± 1°C and 5.0 ± 0.5% CO2 in 0.9 mL fresh assay medium
- after post-incubation followed the MTT assay
Number of replicates:
Three tissue replicates were used for the test item and for the controls.

Results and discussion

In vitro

Resultsopen allclose all
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
Tissue 1
Value:
84.1
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of irritation
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
Tissue 2
Value:
87.4
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of irritation
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
Tissue 2
Value:
82.6
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of irritation
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
Mean
Value:
84.7
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of irritation
Remarks:
± standard deviation: 2.4%
Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system:
not reported
- Direct-MTT reduction:
not direct-MTT reduction observed
- Colour interference with MTT:
no colour interference with MTT observed

DEMONSTRATION OF TECHNICAL PROFICIENCY:

ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control:
Yes; The criterion for optical density of the negative control (≥ 0.8 and ≤ 2.8) was fulfilled: The mean optical density of the three tissues was 1.965. Variation
within replicates (standard deviataion) was 5.2% and therefore within the accepted range (required: ≤ 18%). Values for negative control were within the range of historical data of the test facility.
- Acceptance criteria met for positive control:
Yes; The positive control reduced absorbance to 2.5% compared to the negative control (required ≤ 20%). Variation within replicates (standard deviataion) was 0.2% and therefore within the accepted range (required: ≤ 18%). Values for positive control were within the range of historical data of the test facility.
- Acceptance criteria met for variability between replicate measurements:
Yes; Variation within replicates (standard deviataion) was within the accepted range for negative control, positive control and test item (required: ≤ 18%).
- Range of historical values if different from the ones specified in the test guideline:
Negative control (DPBS buffer) (OD): 0.476 - 2.471
Positive control (5% SDS) (% OD compared to Negative control): 1.8 - 17.1 %

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Remarks:
not irritating to skin
Conclusions:
The results in this in-vitro skin irritation test with the EpiDerm model indicates that the test item dermofeel PA-3 (dried) is not irritant.
Executive summary:

One valid experiment was performed.

Three tissues of the human skin model EpiDermTM were treated with the test item dermofeel PA-3 (dried) for 60 minutes.

The test item was applied directly to each tissue and spread to match the tissue size (0.63 cm2; as indicated by the supplier). DPBS-buffer was used as negative control and 5% SDS solution was used as positive control. After treatment with the negative control, the absorbance values were within the required acceptability criterion of 0.8 ≤ mean OD ≤ 2.8, OD was 2.0. The positive control showed clear irritating effects. The mean value of relative tissue viability was reduced to 2.5% (required: ≤ 20%). The variation within the tissue replicates of negative, control, positive control and test item was acceptable (required: ≤ 18%). For these reasons, the experiment was considered to be valid.

After the treatment with the test item, the mean value of relative tissue viability was reduced

to 84.7 %. This value is above the threshold for skin irritation potential (50%). Test items that induce values above the threshold of 50% are considered non-irritant to skin.

Therefore, dermofeel PA-3 (dried) is considered non-irritant to skin in the Reconstructed human Epidermis (RhE) Test Method.